WAY Price Prediction Next Week
Analysis and Insights
Insider Trading Activity:
Recent insider transactions for Waystar Holding Corp (WAY) indicate significant selling activity. T. Craig Bridge, Chief Transformation Officer, sold 182,914 shares (26% of his holdings), and Paul G. Moskowitz, a director, sold 5,652,689 shares (20.2% of his holdings). This consistent insider selling over the past six months, with no purchases, may signal a lack of confidence in the company's near-term prospects.
Technical Indicators:
- RSI (14): 36.84, indicating the stock is in a bearish zone.
- MACD: The MACD line is slightly above the signal line, suggesting weak upward momentum.
- SMA: The stock is trading below its 20-day and 50-day moving averages, confirming the downtrend.
- Fibonacci Levels: The stock is below the pivot point of $40.63, with resistance at $44.43 and support at $34.49.
Options Activity:
Notable put option activity, particularly for the $37.50 strike expiring March 21, 2025, suggests market participants are positioning for potential downside. This could indicate a bearish sentiment among option traders.
Price Prediction:
Based on the technical indicators and insider activity, the stock is likely to continue its downtrend. The next support level at $34.49 may be tested, with potential to drop further to $32.50 if selling pressure intensifies.
Recommendation:
Sell Waystar Holding Corp (WAY) at the current price of $35.77, as the technical and fundamental factors suggest a bearish outlook for the next trading week.
WAY Similar Chart Price Prediction
The price of WAY is predicted to go up -3.51%, based on the high correlation periods with SSSS. The similarity of these two price pattern on the periods is 90.78%.
WAY
SSSS
Down: -3.51%Similarity: 90.78%
WAY Revenue Forecast
WAY EPS Forecast
WAY FAQs
What is WAY revenue forecast for next quarter？
What is WAY eps forecast for next quarter？
WAY Analyst's Forecast
Jailendra Singh
Truist Securities
Strong Buy
2025-03-14
Price Target
$45
Upside
+23.39%
Truist initiated coverage of Waystar with a Buy rating and $45 price target. The company is positioned to benefit from the evolution that the healthcare payments workflow is currently undergoing where providers are increasingly looking for automated software solutions to reduce administrative burden and improve efficiency, the analyst tells investors in a research note. The firm believes Waystar has approached its 2025 guidance conservatively, and would not be surprised to see another year of "beat and raise" quarters.
Richard Close
Canaccord Genuity
Strong Buy
2025-02-24
Price Target
$42 → $50
Upside
+18.85%
Stephanie Davis
Barclays
Buy
2025-02-19
Price Target
$42 → $50
Upside
+14%
